VITREOMACULAR UPDATE FOR THE PRIMARY CARE OD
|
|
- Moses Cox
- 5 years ago
- Views:
Transcription
1 VITREOMACULAR UPDATE FOR THE PRIMARY CARE OD VITREOMACULAR UPDATE FOR THE PRIMARY CARE OD 1 2 DISCLOSURE STATEMENT I have received lecture honoraria from TearScience. I have no direct financial or proprietary interest in any companies, products or services mentioned in this presentation. VITREOMACULAR UPDATE FOR THE PRIMARY CARE OD Please silence all mobile devices At the conclusion of this course, please properly dispose of your trash as you leave this room 3 To: Text: christopherw667 To participate in audience polling: In the song Yellow Ledbetter what is the first word(s) mumbled by Eddie Vedder? 1. On the ceiling 2. Unsealed 3. One bizarre hymn 4. And the wizard 6 1
2 Inner Nuclear Ganglion Cell Vitreous Inner Plexiform Posterior Hyaloid RNFL Outer Nuclear ELM Outer Plexiform Choroid PIL RPE 7 8 EPIRETINAL MEMBRANE & VITREOMACULAR TRACTION 9 Epiretinal Membrane & Vitreomacular Traction 10 Case 1: 41 year old white female Case 1: 41 year old white female CC: distorted vision after putting a contact in her eye that made her right eye red and irritated I see a blurry circle surrounded by a clear circle FHx: glaucoma OcHx: strabismus OD MHx: depression (Paxil) BVA: OD: x /30 2 OS: x /20 CT: 18 pd CRET Anterior Segment: Unremarkable OU Posterior Segment: Faint circular foveal distortion OD Unremarkable OS
3 Case 1: 41 year old white female Case 1: 41 year old white female Case 1: 41 year old white female 6 weeks later Summary of Care VMT Date Service(s) Price(s) Based on 2017 Medicare NV 7/31/ , 92250, (ABN) $168.50, $68.53, $ /7/ , 92134, (cash), CL eval (cash) $127.79, $42.50, $ 50, $50 15 Total Care: $ Case 2: 16 year old white female Case 2: 16 year old white female CC: mild blurred vision and difficulty with depth perception FHx & MHx: unremarkable OcHx: Blunt trauma OD BVA: OD: x /20 OS: DS 20/20 EOM and CT: full and ortho Anterior Segment: Unremarkable OU Amsler: negative OU Posterior Segment: Vitreoretinal adhesion superiorly with traction and membrane OD Unremarkable OS
4 Case 2: 16 year old white female Case 2: 16 year old white female ERM/VMT RISK FACTORS PVD Prior intraocular surgery Trauma Intraocular inflammation Macular holes TRADITIONAL TREATMENT Monitor If VA is 20/50 or worse consider PPV w/ peel 75% will have improved VA MACULAR HOLES Case 3: 69 year old white male Macular Holes CC: vision has been blurry for about 6 weeks in my left eye FHx: grandmother was blind from some unknown eye disease OcHx: unremarkable MHx: Elevated cholesterol (Lipitor) BVA: OD: x /25 OS: x /100 Anterior Segment: Mild NS OU Amsler: Normal OD, pt can not see center dot OS
5 Case 3: 69 year old white male Posterior Segment: Unremarkable OD Faint circular foveal distortion with fluid cuff and PVD OS Case 3: 69 year old white male Case 3: 69 year old white male 250 microns Macular Hole Fundusoscopy Stages Stage 1 loss of foveal depression with a yellow spot or ring Stage 2 Full thickness hole overlying pseudo operculum Stage 3 Full thickness hole with overlying operculum NO PVD Stage 4 Full thickness hole with overlying operculum W/ PVD VMA/VMT OCT Classification VMA VMT
6 Macular Hole OCT Stages Stage 1 Stage 2 Stage 3 Stage 4 Traditional Treatment for Macular Holes Stage 1 No treatment Spontaneous closure occurs in 50% Stage 2 PPV w/ peeling Intraocular bubble Face down positioning for 1 2 weeks Success is good if MH is less than 1 year in duration Literature Update 28 days after injection non surgical resolution occurred in: VMT: 26.5% Jetrea 10.1% placebo Macular hole 40.6% for all holes Jetrea 58% for holes < 251 microns wide 25% for holes between microns wide 10.6% placebo Literature Update Rate and timing of spontaneous resolution in VMP group: Should the role of watchful waiting be re evaluated as an alternative to Ocriplasmin therapy? Dimopoulos et al, Br J Ophthalmol Mar; 99(3);350 3 Spontaneous VMT Closure Rate: 20 out of 46 patients 43% Time to Spontaneous VMT Closure: Within 1 year Risk of waiting: Macular hole formation in 3 patients, loss of 1 ETDRS letter/ year if VMT is not treated Clinical Take home FOR SMALL HOLES (<250) Absolute Risk Reduction 48% Number Needed to Treat 2 FOR LARGE HOLES ( ) Absolute Risk Reduction 28% Number Needed to Treat
7 Literature Update Based on Jetrea study how many people with macular holes would fall into these classifications: Any stage Macular Hole with VMT 19 eyes (14.1%) Macular Hole < 400 microns w/ VMT 9 eyes (6.7%) Of all the macular holes (125), 9 would be candidates for Jetrea injection and at a 40% closure rate, 2.7% would benefit from Jetrea Cost Effectiveness of Jetrea Literature Update Can macular hole surgery be effective without facedown positioning? Closure rate: 100% Mean Pre op VA: 20/95 Mean Post op VA: 20/ HYDROXYCHLOROQUINE TOXICITY Hydroxychloroquine Toxicity
8 Case 1: CC: vision does not seem as sharp as it has in the past FHx: unremarkable OcHx: Unremarkable MHx: SLE (plaquenil 400 mg PO QD x ~6 years), Wt: 130 BVA: OD: x /20 2 OS: x /20 Anterior Segment: Unremarkable OU Posterior Segment: Unremarkable OU RIGHT MACULA LEFT MACULA RIGHT 10 2 LEFT RIGHT MACULA LEFT MACULA
9 RIGHT MACULA LEFT MACULA AAO screening Recommendations Baseline (within first year of starting Plaquenil) and annually after 5 years DFE 10 2 Automated VF Any of the following: SD OCT mferg FAF Thank You! EyeCode Education Contact Information: EyeCodeQuestions@gmail.com website: Blog:
Often asymptomatic but can cause a reduction in BCVA and distortion of vision.
Christopher Wolfe, OD, FAAO, Dipl. ABO Epiretinal Membrane (ERM) and Vitreomacular Traction (VMT) Epiretinal membrane (macular pucker, cellophane maculopathy, premacular fibrosis) consists of a layer of
More information8/6/17. Disclosures Aerie Pharmaceuticals Alcon BioTissue Diopsys Optovue Shire
Nathan Lighthizer, O.D., F.A.A.O. Associate Professor Assistant Dean for Clinical Care Director of Continuing Education Chief of Specialty Care Clinics Oklahoma College of Optometry Tahlequah, OK lighthiz@nsuok.edu
More informationEarly diagnosis and treatment of VMT with single Intravitreal Injection of Pharmacologic Vitreolysis. Stratos Gotzaridis MD Athens
Early diagnosis and treatment of VMT with single Intravitreal Injection of Pharmacologic Vitreolysis Stratos Gotzaridis MD Athens The Vitreous Body Gel composed of 98-99% water 1% macromolecules Glycoproteins
More information10/3/2018. Case: 63 year old white female 6/11/2012 visit. Glaucoma Update for the Primary Care OD CHRISTOPHER WOLFE, OD, FAAO, DIPL ABO
DISCLOSURE STATEMENT Ihave no direct financial or proprietary interest in any companies, products or services mentioned in this presentation. GLAUCOMA UPDATE FOR THE PRIMARY CARE OD Please silence all
More informationManaging the Vitreomacular Interface
Managing the Vitreomacular Interface A Guide to VMA, VMT, Holes and ERM Anna K. Bedwell, OD, FAAO Indiana University School of Optometry Please silence all mobile devices and remove items from chairs so
More informationHow Strongly Do You Feel That This Patient Has Glaucoma? % % % % %
My Favorite Cases Anthony B. Litwak, OD, FAAO VA Medical Center Baltimore, Maryland Dr. Litwak is a speaker and on advisory boards for Alcon and Zeiss Meditek CASE CR 35 yohf Neg PMH +FOH mother and grandmother
More informationMy Favourite Cases Anthony B. Litwak, OD, FAAO VA Medical Center Baltimore, MD
My Favourite Cases Anthony B. Litwak, OD, FAAO VA Medical Center Baltimore, MD Dr. Litwak is a speaker and on advisory boards for Alcon and Zeiss Meditek CASE CR! 35 YOHF! Neg PMH! +FOH mother and grandmother
More informationHistory/principles of the OCT What does the normal retinal OCT look like Vitreal disorders Retinal/RPE disorders Choroidal disorders
Nathan Lighthizer, O.D., F.A.A.O. Assistant Professor Assistant Dean for Clinical Care Director of Continuing Education Chief of Specialty Care Clinics Chief of Electrodiagnostics Clinic Oklahoma College
More informationCourse # Getting to Know Your OCT
Course # 140 Getting to Know Your OCT Course Title: Lecturer: Getting to Know Your OCT Brad Sutton, OD, FAAO IU School of Optometry Financial Disclosures No financial disclosures Optical Coherence Tomography-OCT
More informationAudit of Macular Hole Surgery, Visual Outcome Prediction on OCT Appearance of Macular Hole
International Journal of Ophthalmology & Visual Science 2017; 2(4): 93-97 http://www.sciencepublishinggroup.com/j/ijovs doi: 10.11648/j.ijovs.20170204.13 Audit of Macular Hole Surgery, Visual Outcome Prediction
More informationOCT Interpretation. Financial Disclosure. Jay M. Haynie, OD, FAAO. OCT Image Layers 7/21/2014
OCT Interpretation Jay M. Haynie, OD, FAAO Financial Disclosure I have received honoraria or am on the advisory board for the following companies: Olympia Tacoma Renton Kennewick - Washington Carl Zeiss
More informationVMA at the macula resulting in VMT
Ocriplasmina for pharmacologic treatment in VMT Teresio Avitabile 1 Introduction PVD is a normal, physiologic process that occurs with aging; however, in some cases, PVD is incomplete Incomplete PVD localized
More informationTreatment Options for VMT and Macular Holes Observation, Surgery, and Pharmacotherapy
Treatment Options for VMT and Macular Holes Observation, Surgery, and Pharmacotherapy Andrew Moshfeghi, MD, MBA Bascom Palmer Eye Institute Palm Beach Gardens, FL Financial Disclosures Salary/Honoraria:
More informationGas for Vitreomacular Traction RCT (Protocol AG) Gas for Macular Hole Single-Arm Study (Protocol AH)
Gas for Vitreomacular Traction RCT (Protocol AG) Gas for Macular Hole Single-Arm Study (Protocol AH) Protocol AG Chair: Clement Chan, MD Protocol AH Chair: Calvin Mein, MD DRCR.net Protocol AG Randomized
More informationVitreomacular interface disorders. Ghanbari MD 1393:10:25
Vitreomacular interface disorders Ghanbari MD 1393:10:25 Human vitreous after dissection of the sclera, choroid, and retina. Lamellar structure of the posterior vitreous cortex (PVC) in the monkey. V =
More informationEPIRETINAL MEMBRANE & VITREOMACULAR TRACTION
EPIRETINAL MEMBRANE & VITREOMACULAR TRACTION Management of ERM and VMT K.V.Chalam,MD,PhD,MBA,FACS Professor and Director of Retina Loma Linda Eye Institute Los Angeles, USA REVIEW ANATOMY The vitreous
More informationMacular Hole. Helpline
Macular Hole The retina is a light-sensitive layer of tissue lining the back of the eye. The macula is a small area at the centre of the retina responsible for all of our central vision, most of our colour
More informationRe(nal and OCT Grand Rounds
Op#cal Coherence Tomography Op(cal: Light- based Re(nal and OCT Grand Rounds Steven Ferrucci, OD, FAAO Chief, Optometry Sepulveda VA Professor, SCCO/MBKU Coherence: property of light waves in which the
More informationThe Foundation WHAT IS THE RETINA? continued next page. RETINA HEALTH SERIES Facts from the ASRS
The Foundation American Society of Retina Specialists Committed to improving the quality of life of all people with retinal disease. Vitreomacular Traction Syndrome The vitreous humor is a transparent,
More informationevaluation of vitreoretinal adhesions in exudative AMD using optical coherence tomography
evaluation of vitreoretinal adhesions in exudative AMD using optical coherence tomography Dr. Mahmoud Alaa Abouhusssein, FRCO Lecturer of ophthalmology, Alexandria university Dr. Amir Ramadan Gomaa, MD
More informationOCT Interpretation in Retinal Disease
OCT Interpretation in Retinal Disease Jay M. Haynie, OD, FAAO Financial Disclosure I have received honoraria or am on the advisory board for the following companies: Carl Zeiss Meditec Advanced Ocular
More informationOptical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)
Columbia International Publishing Journal of Ophthalmic Research (2014) Research Article Optical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)
More informationVitreo-retinal interface pathologies and fibrinolytic treatment approaches
Vitreo-retinal interface pathologies and fibrinolytic treatment approaches Constantin J. Pournaras Memorial A. de Rothschild Clinical Research Group La Colline Ophthalmology Center Vitreoretinal Interface
More informationVitreomacular Traction: Management
Miscellaneous Refractive Surgery Vitreomacular Traction: Management Raji K. MS, DNB Raji K. MS, DNB, A.K. Upadhyay MS, S. Waikar MS, DNB, P. Tiwari MBBS Department of Ophthalmology, Command Hospital (WC)
More informationFinancial Disclosures
Financial Disclosures Consultant Genentech, Regeneron, Allergan, Thrombogenics, Optos, and ArcticDx Grant Support Regeneron, Allergan Mathew W. MacCumber, MD, PhD Professor & Assoc. Chair for Research
More informationSteven Ferrucci, OD. FAAO; Jeffry Gerson, OD, FAAO; Robert Prouty, OD, FAAO; Leo semes OD, FAAO
PARDON THE OBJECTION: RETINA Steven Ferrucci, OD. FAAO; Jeffry Gerson, OD, FAAO; Robert Prouty, OD, FAAO; Leo semes OD, FAAO 1. Introductions/Disclosures (Ferrucci) 2. The genetics of AMD (Gerson) a. Background
More informationOptical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP
Optical Coherence Tomography in Diabetic Retinopathy Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP Content OCT imaging Retinal layers OCT features in Diabetes Some NON DR features
More informationOptical coherence tomography of the vitreoretinal interface in macular hole formation
1092 St Thomas s Hospital, London V Tanner D S Chauhan T L Jackson T H Williamson Correspondence to: Mr V Tanner, Royal Berkshire Hospital, London Road, Reading RG1 5AN, UK tannerone@aol.com Accepted for
More informationOptical Coherence Tomography (OCT)
Understanding and Interpreting OCT Mark Dunbar: Disclosure The Swiss Army Pocket Knife of Eye Care Mark T. Dunbar, O.D., F.A.A.O. Bascom Palmer Eye Institute University of Miami, School of Medicine Consultant
More informationOCT Assessment of the Vitreoretinal Relationship in CSME
December 2007 Sonia Rani John et al. - IFIS 375 ORIGINAL ARTICLE OCT Assessment of the Vitreoretinal Relationship in CSME Dr. Manoj S. DNB FRCS, Dr. Unnikrishnan Nair MS DO FRCS, Dr. Gargi Sathish MS Introduction
More informationThese affiliations will have no affect on the content of this lecture. PVD & RBs: when do I hold and when to refer?
Disclosures From Print to Practice: PVD a common process with potential for ocular morbidity Diana Shechtman OD FAAO I am on The speaker s bureau for: Bausch & Lomb, Zeavision, Carl Zeiss Meditec & Alcon
More informationCase report 12/10/2014. Delphine Lam ; Dr Mayer Srour Service d ophtalmologie Professeur E.Souied Université Paris Est
Case report 12/10/2014 Delphine Lam ; Dr Mayer Srour Service d ophtalmologie Professeur E.Souied Medical history Man, 75 years old Complaint: Vision loss in left eye in June 2014 Past ophthalmologic history:
More informationFoveal Red Spot, Macular Microhole and Foveal Photoreceptor Defect in the Era of High-Resolution Optical Coherence Tomography
1:15 PM Foveal Red Spot, Macular Microhole and Foveal Photoreceptor Defect in the Era of High-Resolution Optical Coherence Tomography Edward F. Hall, MD Steven J. Rose, MD Brian P. Connolly, MD Ernest
More informationOphthalmology Macular Pathways
Ophthalmology Macular Pathways Age related Macular Degeneration Diabetic Macular Oedema Macular Oedema secondary to Central Retinal Macular Oedema secondary to Branch Retinal CNV associated with pathological
More informationRetina Grandrounds. Retinal Grand Rounds Exhibition of Common Entities
Retina Grandrounds Retinal Grand Rounds Exhibition of Common Entities Mohammad R Rafieetary, O.D. mrafieetary@charlesrteina.com Exhibitions 1) Choroidal Neovascular Membrane 2) Vitreomacular Interface
More informationConsulting Fee: Alcon Laboratories
Consulting Fee: Alcon Laboratories Pre-Op EMM Post PPV, Forceps EMM & ILM Peeling 25/27 Gauge, Trans-Conjunctival, Sutureless PPV Inside-Out, End-Grasping Forceps Peeling w/ Alcon 25G End-Grasping DSP
More informationMark Dunbar: Disclosure
Important Things to Understand About OCT Mark T. Dunbar, O.D., F.A.A.O. Bascom Palmer Eye Institute University of Miami, School of Medicine Mark Dunbar: Disclosure Optometry Advisory Board for: Allergan
More informationOcriplasmin for the Treatment of Symptomatic Vitreomacular Adhesion/Traction. Baruch D Kuppermann, MD, PhD
Ocriplasmin for the Treatment of Symptomatic Vitreomacular Adhesion/Traction Baruch D Kuppermann, MD, PhD Professor of Ophthalmology and Biomedical Engineering; Chief, Service; Vice-Chair, Clinical Research,
More informationOCT Angiography The Next Frontier
Choroid Retina avascular 5/13/2017 OCT Angiography The Next Frontier Pierce Kenworthy OD, FAAO June 9, 2017 OCT Angiography (OCTA) 2016 Non-invasive, motion contrast imaging Represents erythrocyte movement
More information11/29/2016 MACULAR MALADIES: TYPICAL & ATYPICAL CASES
MACULAR MALADIES: TYPICAL & ATYPICAL CASES Dawn Pewitt, OD, FAAO Triad Eye Institute, Grove, OK Dpewitt@triadeye.com Disclosure Statement: No financial disclosures COPE 51218-PS Please silence all mobile
More informationRoyal Berkshire Hospital Dunedin Hospital. Prince Charles Eye Unit Pi Princess Margaret Hospital
Vitreoretinal Surgery Mr Vaughan Tanner www.tanner-eyes.co.uk eyes Reading Royal Berkshire Hospital Dunedin Hospital Windsor Prince Charles Eye Unit Pi Princess Margaret Hospital Success rates VR surgery
More informationThe Quick Guide to OCT Mastery 50 Real Cases with Expert Analysis
OPTICAL COHERENCE TOMOGRAPHY The Quick Guide to OCT Mastery 50 Real Cases with Expert Analysis VOL 1 Sanjay Sharma, MD, FRCS, MSc (Epid), MBA Ophthalmologist, Epidemiologist Queen s University, Canada
More informationHere s what you need to know about your treatment with JETREA (ocriplasmin)
Here s what you need to know about your treatment with JETREA (ocriplasmin) JETREA is used to treat adults with an eye disease called vitreomacular traction (VMT), including when it is associated with
More informationΧειρουργική Ωχράσ Κηλίδασ. Γ. Γ. Παππάς, Βεληδέιεηο ΓΝ
Χειρουργική Ωχράσ Κηλίδασ Γ. Γ. Παππάς, Βεληδέιεηο ΓΝ FREQUENCY OF MACULAR SURGERY Incidence= 8 in 100000 (McCannel 2009) Prevalence = between 0.2 (Mitchell 2007) and 3.3 (Baltimore Eye Survey 1996) 2nd
More informationAn A to Z guide on Epiretinal Membranes (ERMs) Paris Tranos PhD,ICO,FRCS OPHTHALMICA Vitreoretinal & Uveitis Department
An A to Z guide on Epiretinal Membranes (ERMs) Paris Tranos PhD,ICO,FRCS OPHTHALMICA Vitreoretinal & Uveitis Department Types of ERM Natural history OCT prognostic factors ERM with co-existing pathology
More informationCase : The glaucoma consult Case: The Glaucoma Consult Case: The Glaucoma Consult Case : The Glaucoma Consult Case : The weekend call you don t want
1 2 3 4 5 6 Case : The glaucoma consult CC: second opinion on glaucoma HPI: OU/ 1 mos/optometrist thinks I have glaucoma/ no Rx yet / no POAG family hx 62 BM, VA OD = 20/40, VA OS = 20/30 NS +1 IOP: 20
More informationFundus Autofluorescence. Jonathan A. Micieli, MD Valérie Biousse, MD
Fundus Autofluorescence Jonathan A. Micieli, MD Valérie Biousse, MD The retinal pigment epithelium (RPE) has many important functions including phagocytosis of the photoreceptor outer segments Cone Rod
More informationATLAS OF OCT. Retinal Anatomy in Health & Pathology by Neal A. Adams, MD. Provided to you by:
ATLAS OF OCT Retinal Anatomy in Health & Pathology by Neal A. Adams, MD Provided to you by: Atlas of OCT The OCT Atlas is written by Neal A. Adams, MD, and produced by Heidelberg Engineering, Inc. to help
More informationOptical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D.
Optical Coherence Tomography: Pearls for the Anterior Segment Surgeon Basic Science Michael Stewart, M.D. Disclosure OCT Optical Coherence Tomography No relevant financial relationships I will refer to
More informationCirrus TM HD-OCT. Details defi ne your decisions
Cirrus TM HD-OCT Details defi ne your decisions 2 With high-defi nition OCT Carl Zeiss Meditec takes you beyond standard spectral domain Built on 10 years experience at the vanguard of innovation, Carl
More informationStudy of clinical significance of optical coherence tomography in diagnosis & management of diabetic macular edema
Original Research Article Study of clinical significance of optical coherence tomography in diagnosis & management of diabetic macular edema Neha Kantilal Desai 1,*, Somesh Vedprakash Aggarwal 2, Sonali
More informationA Curious Case of Bilateral Optic Disc Edema Brittney Dautremont, DO, MPH
A Curious Case of Bilateral Optic Disc Edema Brittney Dautremont, DO, MPH PGY2 Ophthalmology Resident Grandview Medical Center Dayton, OH CASE PRESENTATION 51 year old white female presenting with blurred
More informationThe Future of Retinal Imaging Has Arrived!
Financial Disclosure The Future of Retinal Imaging Has Arrived! Joseph J. Pizzimenti, OD, FAAO Carlo Pelino, OD, FAAO! Pizzimenti:! Honoraria! Kemin! Nicox! Review of Optometry! Optometric Management!
More informationRETINA. OCT in the Optometric Prac4ce OCT. New stuff 11/7/17 AMD. Disclosure Statement
Disclosure Statement OCT in the Optometric Prac4ce Steven Ferrucci, OD, FAAO Chief, Optometry Sepulveda VA Professor, SCCO/MBKU Speakers bureau/advisory Board Alcon B&L Centervue Genentech MacuLogix Optovue
More informationMacular Hole Associated with Vogt-Koyanagi-Harada Disease at the Acute Uveitic Stage
Published online: September 15, 2015 2015 The Author(s) Published by S. Karger AG, Basel 1663 2699/15/0063 0328$39.50/0 This article is licensed under the Creative Commons Attribution-NonCommercial 4.0
More informationIdiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment
OPEN (2013) 27, S1 S21 & 2013 Macmillan Publishers Limited All rights reserved 0950-222X/13 www.nature.com/eye Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology,
More informationOphthalmic Imager Role
MASTER OCT Ophthalmic Photographers Society October 18, 2014 Chicago, IL James B Soque, CRA COA Pamela A Weber, MD Island Retina Shirley, New York Commack, New York Financial Disclosure Genentech Ophthotech
More informationYasser R. Serag, MD Tamer Wasfi, MD El- Saied El-Dessoukey, MD Magdi S. Moussa, MD Anselm Kampik, MD
Microperimetric Evaluation of Brilliant Blue G- assisted Internal Limiting Membrane Peeling By Yasser R. Serag, MD Tamer Wasfi, MD El- Saied El-Dessoukey, MD Magdi S. Moussa, MD Anselm Kampik, MD The internal
More informationOCT Evaluation of the Retina Alison Bozung, OD, FAAO
Alison Bozung, OD, FAAO Rob Wooldridge, OD, FAAO Bozung: No relevant financial relationships with commercial interests Wooldridge: Speakers Bureau/honoraria from Aerie, Alcon, Allergan, Bausch & Lomb,
More informationOPTIC DISC PIT Pathogenesis and Management OPTIC DISC PIT
OPTIC DISC PIT Pathogenesis and Management Abdel-Latif Siam Ain Shams University Cairo Egypt OPTIC DISC PIT Congenital pit is an atypical coloboma usually located on the temporal edge of the disc, associated
More informationPREDICTIVE FACTORS OF VISUAL OUTCOME FOR VITREOMACULAR TRACTION SYNDROME AFTER VITRECTOMY
PREDICTIVE FACTORS OF VISUAL OUTCOME FOR VITREOMACULAR TRACTION SYNDROME AFTER VITRECTOMY Downloaded from https://journals.lww.com/retinajournal by mv7bzw+nz2blpko//cqyhwu2mokppdiwuep6ir1molueskh0dp9rbmb7dum5a2/cp6zifirtq3zbawzt+95f/m61fycawpqbpe8y2wuyzwnns2gw3+gmrxei6x11wu+s
More informationCirrus TM HD-OCT. Details define your decisions
Cirrus TM HD-OCT Details define your decisions 2 With high-definition OCT Carl Zeiss Meditec takes you beyond standard spectral domain Built on 10 years experience at the vanguard of innovation, Carl Zeiss
More informationCase History. Entrance Skills. Disclosures. Legends of the Posterior Segment CASE 1 9/13/2017
Disclosures Legends of the Posterior Segment Blair Lonsberry, MS, OD, MEd., FAAO Professor of Optometry Pacific University College of Optometry blonsberry@pacificu.edu Paid consultant for: Alcon: Honoraria-
More information! Reichert, Alcon, Allergan, CZ & Zeavision. Uchino, E. et al. Arch Ophthalmol ! Vitreoschisis (split within the vitreous)! ERM!
Financial disclosure From Print to Practice: PVD a common process with potential for ocular morbidity! I have received lecture honoraria or serve on the advisory boards or speaker s bureaus of:! Reichert,
More informationDisclosures. Objectives. Small gauge vitrectomy POD 1. The routine postoperative course 1/24/2018. None
Disclosures Retina Surgery: Postoperative Considerations and Complications None D. Wilkin Parke III, M.D. VitreoRetinal Surgery, PA 1 2 Objectives Small gauge vitrectomy To understand the common and serious
More informationCase History. Legends of the Posterior Segment CASE 1 4/22/2018
Legends of the Posterior Segment Blair Lonsberry, MS, OD, MEd., FAAO Professor of Optometry Pacific University College of Optometry blonsberry@pacificu.edu CASE 1 Case History 38 black male, complaining
More informationEccentric Macular Hole after Pars Plana Vitrectomy for Epiretinal Membrane Without Internal Limiting Membrane Peeling: A Case Report
Ophthalmol Ther (2017) 6:391 395 DOI 10.1007/s40123-017-0113-7 CASE REPORT Eccentric Macular Hole after Pars Plana Vitrectomy for Epiretinal Membrane Without Internal Limiting Membrane Peeling: A Case
More informationRETINA 2018 OBJECTIVES OCT VERY USEFUL INFORMATION SAFE AND FRIENDLY 1/11/2018 KELLY MITCHELL
RETINA 2018 KELLY MITCHELL OBJECTIVES HIGHLIGHT NEW DIAGNOSTIC & TREATMENT OPTIONS REVIEW DIAGNOSTIC KEYS OF SELECT RETINAL DISEASES DISCUSS USE OF IMAGING AND REFERRAL RECOURSES FOR PATIENT BENEFIT OCT
More informationPROSPECTIVE THREE-DIMENSIONAL ANALYSIS OF STRUCTURE AND FUNCTION IN VITREOMACULAR ADHESION CURED BY PHARMACOLOGIC VITREOLYSIS
PROSPECTIVE THREE-DIMENSIONAL ANALYSIS OF STRUCTURE AND FUNCTION IN VITREOMACULAR ADHESION CURED BY PHARMACOLOGIC VITREOLYSIS Kevin R. Tozer, BS,* Wolfgang Fink, PhD, ** Alfredo A. Sadun, MD, PhD, FARVO,
More informationLearn Connect Succeed. JCAHPO Regional Meetings 2017
Learn Connect Succeed JCAHPO Regional Meetings 2017 How Retinal Imaging Guides Treatment Odette Margit Houghton MD Question 1 Which OCT has the highest resolution? A: Swept source OCT B: Spectral domain
More informationRetrospective study on outcome of macular hole surgery
Original article Singh S, Byanju R, Pradhan S, Lamichhane G. Bharatpur Eye Hospital,Bharatpur Abstract Introduction: Macular hole is a common and treatable cause of central visual loss. Classic macular
More informationDisclosures. Definitions. Goals. Imaging and glaucoma 3/22/2016
Pinakin Davey OD, PhD, FAAO Professor and Director of Research Disclosures Principal investigator for ivue OCT trial Principal investigator Topcon FDA trials for Maestro and OCT 2000 Consultant for Topcon
More informationDiabetic Retinopathy: Managing the Extremes. J. Michael Jumper, MD West Coast Retina
Diabetic Retinopathy: Managing the Extremes J. Michael Jumper, MD West Coast Retina Case 1: EC 65 y.o. HM No vision complaints Meds: Glyburide Metformin Pioglitazone Va: 20/20 OU 20/20 Case 2: HS 68 y.o.
More informationGanglion cell analysis by optical coherence tomography (OCT) Jonathan A. Micieli, MD Valérie Biousse, MD
Ganglion cell analysis by optical coherence tomography (OCT) Jonathan A. Micieli, MD Valérie Biousse, MD Figure 1. Normal OCT of the macula (cross section through the line indicated on the fundus photo)
More informationMacular Holes. The Retina
Macular Holes This information leaflet aims to give you some information about the condition of Macular Holes. It is a common causes of poor vision amongst retired people. So What is a Macular Hole? This
More informationFALSE! True or False: Back to Basics. Key to Retinal Assessment: Making Visible what is Invisible Jerome Sherman
Key to Retinal Assessment: Making Visible what is Invisible Jerome Sherman Disclosure: Dr. Sherman has lectured and received honorarium from Carl Zeiss Meditec, Topcon, Optovue, Optos, Eye Solutions, PHP,
More informationWhen optical coherence tomography (OCT)
Macular Imaging: SD-OCT in nterior Segment Surgical Practice Many pathologic processes of the macula can be visualized or quantified only with this modality. y Steven G. Safran, MD When optical coherence
More informationABCs. ABCs of retinal disease !"#$"%!& Disclosures. ABCs three major threats to vision where 1 o care intervention may be helpful!a = AMD !
Disclosures Stockholder: HPO ABCs of retinal disease Honoraria, Consultant or Advisory Board: Alcon, Allergan, B&L, Arctic Dx, Sucampo, Zeiss. Idaho Optometric Physicians 2016 Leo Semes, OD, FAAO ABCs
More informationCLINICAL COURSE OF VITREOMACULAR ADHESION MANAGED BY INITIAL OBSERVATION
CLINICAL COURSE OF VITREOMACULAR ADHESION MANAGED BY INITIAL OBSERVATION VISHAK J. JOHN, MD,* HARRY W. FLYNN, JR., MD,* WILLIAM E. SMIDDY, MD,* ADAM CARVER, MD, ROBERT LEONARD, MD, HOMAYOUN TABANDEH, MD,
More informationBilling Requirements for Intravitreal Injections. Financial Interest. Indications. Documentation. Documentation. Documentation
Billing Requirements for Intravitreal Injections Financial Interest ASCRS ASOA Symposium & Congress Practice Management Program Los Angeles, California May 5-9, 2017 Presented by: Patricia Kennedy, COMT,
More informationHOCT-1I 1F All-in-One Optical Coherence Tomography with Fundus
HOCT-1I 1F All-in-One Optical Coherence Tomography with Fundus Specification Type Resolution(in Tissue) A scan Rate Scan Range SD-OCT / Fundus Z :6~7um, XY:20um 68,000 A-scan/sec. [Fundus] X:6-12mm, Y:6-9mm,
More informationJay M. Haynie, O.D.; F.A.A.O. Olympia Tacoma Renton Kennewick Washington
Jay M. Haynie, O.D.; F.A.A.O. Olympia Tacoma Renton Kennewick Washington I Jay M. Haynie, OD, FAAO have received honoraria from the following companies: Reichert Technologies Notal Vision Carl Zeiss Meditec
More informationRelated Policies None
Medical Policy BCBSA Ref. Policy: 9.03.30 Last Review: 03/29/2018 Effective Date: 03/29/2018 Section: Other Related Policies None DISCLAIMER Our medical policies are designed for informational purposes
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT JETREA 0.5 mg/0.2 ml concentrate for solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains
More informationDermatologic and Ophthalmic Drugs Advisory Committee Meeting Briefing Package. for. Ocriplasmin Intravitreal Injection, 2.5 mg/ml.
Food and Drug Administration Center for Drug Evaluation and Research Division of Transplant and Ophthalmology Products Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Briefing Package for
More informationGoals of this Course. Imaging Technologies. Imaging Technologies. The Future of Retinal Imaging Has Arrived! Richard Spaide, MD NY Retina Consultants
The Future of Retinal Imaging Has Arrived! William Jones, OD Steven Ferrucci, OD Joseph J. Pizzimenti, OD (moderator) Optometric Retina Society Goals of this Course! To provide an overview of PS Imaging!
More informationM acular microholes have been described in patients
189 EXTENDED REPORT Macular microholes: pathogenesis and natural history H J Zambarakji, P Schlottmann, V Tanner, A Assi, Z J Gregor... See end of article for authors affiliations... Correspondence to:
More informationOcriplasmin for Treatment of Vitreomacular Traction: An Update
Ophthalmol Ther (2016) 5:147 159 DOI 10.1007/s40123-016-0062-6 REVIEW Ocriplasmin for Treatment of Vitreomacular Traction: An Update Mohammed Ali Khan. Julia A. Haller Received: July 22, 2016 / Published
More informationPatient 1. Grand Rounds. Medical History. Ocular History. Medications. Exam 10/28/ year old African American male. Blur OD x 3 months
Patient 1 Grand Rounds Anthony DeWilde, OD 72 year old African American male Blur OD x 3 months Last eye exam 10 years ago Ocular History Medical History Mixed Mechanism Glaucoma S/P LPI OU Was on Xalatan
More informationDiagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City
Diagnosis and treatment of diabetic retinopathy Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City Disclosures Consulted for Novo Nordisk 2017,2018. Will be discussing
More informationOutline. Outline. Vitreous Development & Anatomy OPT - 243
2010 OPT - 243 Vitreous Disorders & Vitreoretinal Disorders of the Posterior Pole I Leo Semes, OD, FAAO 100% 0% 0% 0% 0% Which of these gives the best resolution for studying vitreoretinal disorders of
More informationPATIENT INFORMATION LEAFLET MACULAR HOLE. What is the macula?
What is the macula? The back of the eye has a light-sensitive lining called the retina, similar to the film in a camera. Light is focused through the eye onto the retina, allowing us to see. The centre
More informationCase History. Legends of the Posterior Segment. Entrance Skills 10/4/2018
Case History Legends of the Posterior Segment Blair Lonsberry, MS, OD, MEd., FAAO Professor of Optometry Pacific University College of Optometry blonsberry@pacificu.edu 38 black male, complaining that
More informationRe)nal and OCT Grand Rounds. What's new in OCT? Principles of AngioVue OCTA. Vascular Imaging No Referral Needed 3/9/18. Spectral Domain: Many Op3ons
Spectral Domain: Many Op3ons Re)nal and OCT Grand Rounds Steven Ferrucci, OD, FAAO Chief, Optometry Sepulveda VA Professor, SCCO/MBKU Ease of use Customer support Integra)on of other technology FAF Color
More informationCORRELATION BETWEEN CENTRAL FOVEAL THICKNESS AND VISUAL ACUITY IN PATIENTS WITH IDIOPATHIC VITREOMACULAR TRACTION
CORRELATION BETWEEN CENTRAL FOVEAL THICKNESS AND VISUAL ACUITY IN PATIENTS WITH IDIOPATHIC VITREOMACULAR TRACTION MEHMET M. UZEL, MD, MEHMET CITIRIK, MD, CAGRI ILHAN, MD, KEMAL TEKIN, MD Purpose: To evaluate
More informationOUTCOME OF MACULAR HOLE SURGERY AT KIKUYU EYE UNIT
OUTCOME OF MACULAR HOLE SURGERY AT KIKUYU EYE UNIT A dissertation submitted in part fulfillment for the degree of Master of Medicine (Ophthalmology), University of Nairobi 2014. DR MUFADDAL FAKHRUDDIN
More informationEpiretinal membrane. What is an epiretinal membrane?
Patient information Epiretinal membrane We hope this information will answer some of your questions about epiretinal membrane. If there is anything you do not understand, or if you have any concerns, please
More information3/6/2014. Hoda MH Mostafa MD Associate Professor of Ophthalmology Cairo University. The author has no proprietary interest. Today s Objectives
Hoda MH Mostafa MD Associate Professor of Ophthalmology Cairo University The author has no proprietary interest Today s Objectives Identify the CLINICAL SCENARIOS IN MACULAR EDEMA where OCT plays a MAJOR
More informationRetina Conference. Janelle Fassbender, MD, PhD University of Louisville Department of Ophthalmology and Visual Sciences 09/04/2014
Retina Conference Janelle Fassbender, MD, PhD University of Louisville Department of Ophthalmology and Visual Sciences 09/04/2014 Subjective CC/HPI: 64 year old Caucasian female referred by outside ophthalmologist
More informationClinical Ocular Grand Rounds
Clinical Ocular Grand Rounds SRC 2013 Melbourne, Australia Blair Lonsberry, MS,, MEd., FAAO Diplomate, American Board of Optometry Clinic Director and Professor of Optometry Pacific University College
More information